Agreed. That collaboration could be VERY profitable if the treatment works. And it looks like today might be a true-blue, not one of those 6 steps forward and 7 back sort-of-days.
"Scientists say they have discovered that superbugs known as vancomycin-resistant enterococci, or VRE, appear to be becoming more tolerant to alcohol."
Not sure who you mean? There's been a core of consistent supporters for ages although some have admitted moving their comments to Twitter, not something I follow.
Yes, Aviva have been a pain elsewhere too. As for Lonza, sensible suggestion given the overlap but what we don't know is whether they need any outside expertise? Rather them than a US takeover....